Correlation Between IShares Genomics and IShares Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Genomics and IShares Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and IShares Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Genomics Immunology and iShares Global Clean, you can compare the effects of market volatilities on IShares Genomics and IShares Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of IShares Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and IShares Global.

Diversification Opportunities for IShares Genomics and IShares Global

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between IShares and IShares is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and iShares Global Clean in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Global Clean and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with IShares Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Global Clean has no effect on the direction of IShares Genomics i.e., IShares Genomics and IShares Global go up and down completely randomly.

Pair Corralation between IShares Genomics and IShares Global

Given the investment horizon of 90 days iShares Genomics Immunology is expected to generate 0.78 times more return on investment than IShares Global. However, iShares Genomics Immunology is 1.29 times less risky than IShares Global. It trades about 0.03 of its potential returns per unit of risk. iShares Global Clean is currently generating about -0.12 per unit of risk. If you would invest  2,445  in iShares Genomics Immunology on August 30, 2024 and sell it today you would earn a total of  20.00  from holding iShares Genomics Immunology or generate 0.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

iShares Genomics Immunology  vs.  iShares Global Clean

 Performance 
       Timeline  
iShares Genomics Imm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Genomics Immunology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, IShares Genomics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
iShares Global Clean 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Global Clean has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the ETF investors.

IShares Genomics and IShares Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Genomics and IShares Global

The main advantage of trading using opposite IShares Genomics and IShares Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, IShares Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Global will offset losses from the drop in IShares Global's long position.
The idea behind iShares Genomics Immunology and iShares Global Clean pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm